Ashish Mandelia - Sep 5, 2023 Form 4 Insider Report for Mersana Therapeutics, Inc. (MRSN)

Role
VP, Chief Accounting Officer
Signature
/s/ Alejandra Carvajal, as attorney-in-fact
Stock symbol
MRSN
Transactions as of
Sep 5, 2023
Transactions value $
$0
Form type
4
Date filed
9/7/2023, 05:55 PM
Previous filing
Jan 18, 2023
Next filing
Feb 16, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRSN Restricted stock unit Award $0 +30K $0.00 30K Sep 5, 2023 Common Stock 30K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents the contingent right to receive one share of common stock of the Issuer.
F2 The RSUs will vest on October 1, 2024, subject to the Reporting Person's continued service to the Issuer on such vesting date.